Parameter | G1 mean ± SD (N = 50) | G2 mean ± SD (N = 50) | G3 mean ± SD (N = 50) | Significance Level | ||
---|---|---|---|---|---|---|
G1 vs. G2 | G1 vs. G3 | G2 vs. G3 | ||||
Age (Min–Max) (Male–Female) | 45.06 ± 10.81 (28–66) (23–27) | 45.70 ± 10.36 (25–64) (25–25) | 47.64 ± 9.936 (30–67) (29–21) | NS | NS | NS |
WBC (count/μl) (Min–Max) | 6314 ± 1577 (3200–9850) | 5295 ± 1261 (2890–8200) | 5373 ± 1227 (3040–8050) | 0.0017 | 0.0038 | NS |
Neutrophil (count/μl) (Min–Max) | 4326 ± 1128 (1520–6900) | 3914 ± 1092 (1730–6460) | 4209 ± 1099 (1620–6610) | NS | NS | NS |
Lymphocyte (count/μl) (Min–Max) | 1639 ± 529.4 (770–3220) | 1000 ± 325.3 (300–1865) | 704.4 ± 268.8 (110–1500) |  < 0.0001 |  < 0.0001 |  < 0.0001 |
BMI (kg/m2) | 25.48 ± 2.144 | 25.40 ± 1.801 | 26.03 ± 2.008 | NS | NS | NS |
SBP (mmHg) | 114.2 ± 11.39 | 115.8 ± 11.52 | 116.7 ± 13.01 | NS | NS | NS |
DBP (mmHg) | 73.76 ± 6.989 | 75.10 ± 7.424 | 74.26 ± 7.695 | NS | NS | NS |
FBS (mg/dl) | 99.80 ± 16.05 | 111.6 ± 28.15 | 128.7 ± 38.65 | 0.0356 |  < 0.0001 | 0.0383 |
TG (mg/dl) | 130.1 ± 40.09 | 154.8 ± 51.64 | 178.0 ± 39.81 | 0.0270 |  < 0.0001 | 0.0397 |
Cholesterol (mg/dl) | 156.5 ± 39.39 | 177.5 ± 37.69 | 185.6 ± 31.90 | 0.0227 | 0.0003 | NS |
HDL (mg/dl) | 51.04 ± 6.163 | 49.56 ± 8.501 | 48.03 ± 7.241 | NS | NS | NS |
LDL (mg/dl) | 98.76 ± 29.62 | 120.2 ± 24.56 | 117.7 ± 35.96 | 0.0005 | 0.0146 | NS |
Albumin (g/dl) | 3.510 ± 0.2190 | 3.370 ± 0.4063 | 3.298 ± 0.3034 | NS | 0.0004 | NS |
Creatinine (mg/dl) | 1.619 ± 1.061 | 1.441 ± 0.8133 | 1.406 ± 0.6645 | NS | NS | NS |
GFR (cc/min) | 74.48 ± 21.66 | 71.52 ± 27.78 | 65.52 ± 22.51 | NS | NS | NS |
Clinically COVID-19 Positive Subjects (CT-Scan/PCR) | - - | 50 (16–50) | 50 (50–50) | - - | - - | - - |